ArticleFrontiers in immunology2025

Association of type 2 diabetes, hypertension, and hyperlipidemia with immune-related adverse events in patients undergoing immune checkpoint inhibitors therapy.

Ruidan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.